Literature DB >> 2879310

Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.

G Chouinard, L Annable, A Ross-Chouinard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2879310

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


× No keyword cloud information.
  7 in total

1.  Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.

Authors:  Yasunori Oda; Yuko Fujita; Kengo Oishi; Yusuke Nakata; Masayuki Takase; Tomihisa Niitsu; Nobuhisa Kanahara; Yukihiko Shirayama; Kenji Hashimoto; Masaomi Iyo
Journal:  Psychopharmacology (Berl)       Date:  2017-07-25       Impact factor: 4.530

Review 2.  Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia.

Authors:  Yasunori Oda; Nobuhisa Kanahara; Masaomi Iyo
Journal:  Int J Mol Sci       Date:  2015-12-17       Impact factor: 5.923

3.  Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis.

Authors:  Remiko Kobayashi; Yasunori Oda; Ryunosuke Hayatsu; Nozomi Ohki; Misa Akutsu; Takahiro Oiwa; Hideki Komatsu; Tomihisa Niitsu; Tsuyoshi Sasaki; Masaomi Iyo
Journal:  SAGE Open Med Case Rep       Date:  2020-06-07

Review 4.  Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.

Authors:  Nobuhisa Kanahara; Hiroshi Kimura; Yasunori Oda; Fumiaki Ito; Masaomi Iyo
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

5.  Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting.

Authors:  Inge van Rossum; Diederik Tenback; Jim van Os
Journal:  BMC Psychiatry       Date:  2009-04-28       Impact factor: 3.630

6.  Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia.

Authors:  Yasunori Oda; Nobuhisa Kanahara; Hiroshi Kimura; Hiroyuki Watanabe; Kenji Hashimoto; Masaomi Iyo
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-29       Impact factor: 2.570

7.  Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia.

Authors:  Chia-Hao Ma; Hung-Yu Chan; Ming H Hsieh; Chen-Chung Liu; Chih-Min Liu; Hai-Gwo Hwu; Ching-Hua Kuo; Wei J Chen; Tzung-Jeng Hwang
Journal:  Ther Adv Psychopharmacol       Date:  2022-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.